Column from Byung Eun Ahn, Head of Medical AI Division

29 May 2023

The world's largest international medical information and communication technology event, HIMSS (Healthcare Information and Management Systems Society), recently concluded successfully in Chicago, USA. 


HIMSS is a venue where health and medical experts from around the world can participate to discuss the possibility of medical data and technologies such as artificial intelligence (AI) and cloud in more depth. 


HIMSS USA at this year was filled with so many people at McCormick Place that the memories of the COVID-19 pandemic were overshadowed. About 35,000 people visited the venue, and 1,200 companies, compared to 20% increase from last year, participated in the exhibition to showcase their items. 


I extracted keywords from this year's HIMSS, it would be △Generative AI (generative artificial intelligence) and △Healthcare Data Interoperability. 


The craze of the generative artificial intelligence "Chat GPT," which has been a hot topic since the fourth quarter of last year, was felt throughout the HIMSS, and many companies and industry officials have already stressed that 'ChatGPT' will cause a perceptual change in the medical industry. 


For example, Microsoft was explaining the direction for task optimization from a workflow perspective. When I saw the function of converting medical staff's clinical notes into languages that are easy for the general public to understand and immediately transferring them to the mail format, I felt that the burden of work was reduced even though I was not a medical staff. Even globally, interest in the work efficiency of medical staff in the clinical field was gradually increasing. 


Second, we paid more attention to QHIN (Qualified Health Information Network) from the perspective of 'healthcare data interoperability'. If selected as QHIN, medical information can be exchanged between selected institutions in accordance with the Trusted Exchange Framework Common Agreement (TEFCA) regulations. A total of six companies were selected as QHINs in the first quarter of this year, including large companies such as EPIC, but startups such as Health Gorilla were also included, so it was expected how highly flexible the project would be in a complex U.S. environment. 


Following the HIMSS held in Orlando last year, AITRICS participated in the main event as a sole booth. This year, under the slogan of "New Pathways of Healthcare," it introduced its AI Solution for predicting Patient Deterioration, "AITRICS-VC (VitalCare)" to the global market and planned to develop a business to enter overseas markets. 


VitalCare is an AI-based medical device that predicts ▲the risk of Sepsis in GW within 4 hours ▲the risk of Major Adverse Events (Mortality, Unexpected ICU Transfer, CPR) in GW within 6 hours ▲the risk of Mortality in ICU within 6 hours. Following the selection of innovative medical devices in December last year, it was selected as a new medical technology for evaluation in January, attracting great attention from the industry. 


As a result, many Koreans, including domestic hospital officials, medical staff, government and startup officials, also visited their booths, and  the interest and status of HIMSS in Korea increased compared to last year. 


The part that received the most attention in the United States was by far the "domestic licensing and non-payment use of VitalCare." Hospital officials, medical equipment, and consulting companies of various nationalities, including the U.S., the Netherlands, and Singapore, visited the booth to show interest in their solutions, and the market for artificial intelligence prediction solutions was in the spotlight as they demonstrated their products to actual booth visitors. In addition, expectations for usefulness in real world data (RWD) have also risen in the future. 


For AITRICS, HIMSS was the first foothold for its global expansion. In general if we analyze the conference for at least five years, you will see a bigger trend, but in a short sense, it is a time when the demand for various information processing interoperability and artificial intelligence are combined on the computerized environment after the CMS (Electronic Medical Record) incentive program. 


At HIMSS, which will be held in Orlando in 2024, we are looking forward to the diversity and speed of what solutions will develop to meet the needs of patients, hospitals, and institutions. 


Link to Article >> https://han.gl/iggORg

AITRICS Corp.

Tel: +82-2-569-5507

Cs: +82-2-585-5506

13F, 218, Teheran-ro, Gangnam-gu, Seoul, Republic of Korea Seoul, South Korea


Contact: contact@aitrics.com

Career: career@aitrics.com


Privacy Policy


Company            Tech                    Products          

About                    Publication           AITRICS-VC

News

AITRICS Co., Ltd.

Tel : +82-2-569-5507  I  CS : +82-2-585-5506

13F, 218, Teheran-ro, Gangnam-gu, Seoul, Republic of Korea Seoul, South Korea, 06221

Contact : contact@aitrics.com  I  Career : career@aitrics.com